Dialog window

Development journey

Services

Bio|Verse®

Case studies

About

Careers

News

Blogs

Let’s discuss how we can turn your data into real scientific impact.

Contact us >

How spatial biology improves clinical trial success in oncology

How spatial biology improves clinical trial success in oncology

by Kathryn | Feb 26, 2026 | Blog

In oncology, the drug development path is unique: Phase 0 and Phase I trials are typically conducted in patients rather than healthy volunteers, allowing for early assessment of efficacy and patient selection alongside safety. Yet, even with this early clinical...
Why bioinformatics workflows require experienced software engineers

Why bioinformatics workflows require experienced software engineers

by mandy | Nov 20, 2025 | Blog

In the world of AI, life sciences is an exciting space to work. New models and algorithms appear almost on a daily basis, helping us to understand how biology works, and how we can do things like diagnosing human health, designing new drugs, or building new microbial...
Transforming veterinary research using data science, one paw at a time

Transforming veterinary research using data science, one paw at a time

by mandy | Nov 28, 2024 | Blog, Publications

Data science is vastly changing the way we do research. Veterinary research is, however, still lagging behind its human counterpart. Why is this the case and can we learn from human health data to close this gap? Published by: BioVox on November 27, 2024 – link...
Biomarker discovery 2.0: Using new technologies to access novel insights into human health and disease

Biomarker discovery 2.0: Using new technologies to access novel insights into human health and disease

by mandy | Sep 18, 2024 | Blog

Due to the size and dimensionality of the datasets required, data science is an essential component of modern biomarker discovery and development. It’s no longer feasible to mine and process these data sets manually, which demands collaboration between R&D...
Beyond diagnostics: How biomarkers can be used to de-risk drug development

Beyond diagnostics: How biomarkers can be used to de-risk drug development

by mandy | Aug 28, 2024 | Blog

Biomarker discovery is important not only in the pursuit of better diagnostics but also for de-risking drug development. By leveraging validated biomarkers, you can prioritize drug candidates with higher likelihoods of therapeutic success, thereby reducing the risk of...
Microbial network analysis: How to unravel interactions between taxa

Microbial network analysis: How to unravel interactions between taxa

by mandy | Jul 17, 2024 | Blog

Studying the plant microbiome tells us which phyla, families or species (collectively referred to as ‘taxa’) are present in and around the plant, and how abundant they are. For example, the bacterial phyla Proteobacteria, Bacteroidetes, Firmicutes and Actinobacteria...
« Older Entries

Recent Posts

  • How spatial biology improves clinical trial success in oncology
  • BioLizard Wins 2025 BioTech Breakthrough Award For “Bioinformatics Innovation of the Year”
  • Why bioinformatics workflows require experienced software engineers
  • Industry leader and multi-omics pioneer joins leadership team to advance AI-driven solutions
  • The Vlerick Venture Award 2025 goes to Liesbeth Ceelen

Recent Comments

No comments to show.

Stay informed & inspired

Sign up for the BioLizard newsletter to receive monthly updates on our latest news & insights from the intersection of biology and data science.

Sign up →

Follow us

  • Follow
  • Follow
  • Follow

Recognized by

Headquarters

BioLizard nv
Foreestelaan 88
9000
Ghent, Belgium

US Office

BioLizard Inc.
IMS 1700 W Irving Park Rd Ste 209A
Chicago, IL
60613 USA

NL Office

BioLizard bv
Herengracht 420
1017 BZ Amsterdam, Netherlands

CH Office

BioLizard SA
Digital Health Hub – Biopôle
Bâtiment Phenyl Rte de la Corniche 3 1066 Epalinges, Switzerland

©2026 BioLizard nv. All rights reserved.

Privacy policy